Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP11B1 | P15538 | 11/20 | 0.53 |
| ▸ | CYP11B2 | P19099 | 11/20 | 0.53 |
| ▸ | CYP19A1 | P11511 | 6/20 | 0.49 |
| ▸ | DYRK1A | Q13627 | 2/20 | 0.47 |
| ▸ | NFATC1 | O95644 | 1/20 | 0.47 |
| ▸ | GSK3B | P49841 | 1/20 | 0.47 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.46 |
| ▸ | KDM4C | Q9H3R0 | 1/20 | 0.43 |
| ▸ | LMNA | P02545 | 1/20 | 0.40 |
| ▸ | HTT | P42858 | 1/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.40 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.40 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.40 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.40 |
| ▸ | HPGD | P15428 | 1/20 | 0.40 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4855278 | 0.87 | CYP11B1 (0.42) | CYP11B1CYP11B2CYP19A1DYRK1ANFATC1 | |
| SCHEMBL4857588 | 0.85 | CYP19A1 (0.50) | CYP11B1CYP11B2CYP19A1DYRK1ANFATC1 | |
| SCHEMBL4859078 | 0.83 | DYRK1A (0.51) | CYP11B1CYP11B2CYP19A1DYRK1ANFATC1 | |
| SCHEMBL4849658 | 0.82 | DYRK1A (0.67) | CYP11B1CYP11B2CYP19A1DYRK1ANFATC1 | |
| SCHEMBL4857531 | 0.82 | DYRK1A (0.66) | CYP11B1CYP11B2CYP19A1DYRK1ANFATC1 | |
| SCHEMBL29801631 | 0.82 | DYRK1A (0.66) | CYP11B1CYP11B2CYP19A1DYRK1ANFATC1 | |
| SCHEMBL4856202 | 0.80 | TBXAS1 (0.50) | CYP19A1DYRK1ANFATC1GSK3B | |
| SCHEMBL20604603 | 0.79 | CYP19A1 (0.46) | CYP11B1CYP11B2CYP19A1LMNAHTT | |
| SCHEMBL4859131 | 0.78 | FNTA (0.46) | DYRK1ANFATC1GSK3BALDH1A1 | |
| SCHEMBL20604642 | 0.78 | HTT (0.49) | CYP11B1CYP11B2CYP19A1LMNAHTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7456169-B2 | Heterocyclic kinase inhibitors | ABBOTT LABORATORIES INC. (US) | 2008-11-25 | — | — | US | disclosed |
| US-20070254867-A1 | Heterocyclic Kinase Inhibitors | ABBVIE INC. | 2007-11-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070254867-A1 | Heterocyclic Kinase Inhibitors | MAP3K20, MAP3K19, MAP4K2 | CYP11B1 2685/4885CYP11B2 2636/4885CYP19A1 1766/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.